Abingdon Health Plc (LON:ABDX – Get Free Report)’s share price rose 9.7% during trading on Tuesday . The stock traded as high as GBX 8.50 ($0.11) and last traded at GBX 7.95 ($0.10). Approximately 435,852 shares were traded during mid-day trading, an increase of 101% from the average daily volume of 216,733 shares. The stock had previously closed at GBX 7.25 ($0.09).
Abingdon Health Trading Down 2.2 %
The company has a current ratio of 1.95, a quick ratio of 1.96 and a debt-to-equity ratio of 46.64. The stock has a market capitalization of £14.37 million, a price-to-earnings ratio of -899.00 and a beta of 0.13. The business has a 50 day simple moving average of GBX 7.84 and a 200-day simple moving average of GBX 9.33.
Abingdon Health Company Profile
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Featured Stories
- Five stocks we like better than Abingdon Health
- What is the Australian Securities Exchange (ASX)
- Stock Buybacks Outperform Dividends: Here’s the Key Advantage
- What is the Nikkei 225 index?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Profitably Trade Stocks at 52-Week Highs
- Why Now Is the Ultimate Time to Invest in Oil Stocks
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
